130 related articles for article (PubMed ID: 15588075)
1. 2,3-diaminopyridine bradykinin B1 receptor antagonists.
Kuduk SD; Ng C; Feng DM; Wai JM; Chang RS; Harrell CM; Murphy KL; Ransom RW; Reiss D; Ivarsson M; Mason G; Boyce S; Tang C; Prueksaritanont T; Freidinger RM; Pettibone DJ; Bock MG
J Med Chem; 2004 Dec; 47(26):6439-42. PubMed ID: 15588075
[TBL] [Abstract][Full Text] [Related]
2. Cyclopropylamino acid amide as a pharmacophoric replacement for 2,3-diaminopyridine. Application to the design of novel bradykinin B1 receptor antagonists.
Wood MR; Schirripa KM; Kim JJ; Wan BL; Murphy KL; Ransom RW; Chang RS; Tang C; Prueksaritanont T; Detwiler TJ; Hettrick LA; Landis ER; Leonard YM; Krueger JA; Lewis SD; Pettibone DJ; Freidinger RM; Bock MG
J Med Chem; 2006 Feb; 49(4):1231-4. PubMed ID: 16480259
[TBL] [Abstract][Full Text] [Related]
3. Potent bradykinin B1 receptor antagonists: 4-substituted phenyl cyclohexanes.
Su DS; Lim JL; Markowitz MK; Wan BL; Murphy KL; Reiss DR; Harrell CM; O'Malley SS; Ransom RW; Chang RS; Pettibone DJ; Tang C; Prueksaritanont T; Freidinger RM; Bock MG
Bioorg Med Chem Lett; 2007 Jun; 17(11):3006-9. PubMed ID: 17428657
[TBL] [Abstract][Full Text] [Related]
4. Development of orally bioavailable and CNS penetrant biphenylaminocyclopropane carboxamide bradykinin B1 receptor antagonists.
Kuduk SD; Di Marco CN; Chang RK; Wood MR; Schirripa KM; Kim JJ; Wai JM; DiPardo RM; Murphy KL; Ransom RW; Harrell CM; Reiss DR; Holahan MA; Cook J; Hess JF; Sain N; Urban MO; Tang C; Prueksaritanont T; Pettibone DJ; Bock MG
J Med Chem; 2007 Jan; 50(2):272-82. PubMed ID: 17228869
[TBL] [Abstract][Full Text] [Related]
5. A new class of bradykinin 1 receptor antagonists containing the piperidine acetic acid tetralin core.
Fotsch C; Biddlecome G; Biswas K; Chen JJ; D'Amico DC; Groneberg RD; Han NB; Hsieh FY; Kamassah A; Kumar G; Lester-Zeiner D; Liu Q; Mareska DA; Riahi BB; Wang YJ; Yang K; Zhan J; Zhu J; Johnson E; Ng G; Askew BC
Bioorg Med Chem Lett; 2006 Apr; 16(8):2071-5. PubMed ID: 16464576
[TBL] [Abstract][Full Text] [Related]
6. Bradykinin B1 antagonists: SAR studies in the 2,3-diaminopyridine series.
Kuduk SD; Chang RK; Ng C; Murphy KL; Ransom RW; Tang C; Prueksaritanont T; Freidinger RM; Pettibone DJ; Bock MG
Bioorg Med Chem Lett; 2005 Sep; 15(17):3925-9. PubMed ID: 15993596
[TBL] [Abstract][Full Text] [Related]
7. Potent nonpeptide antagonists of the bradykinin B1 receptor: structure-activity relationship studies with novel diaminochroman carboxamides.
Biswas K; Li A; Chen JJ; D'Amico DC; Fotsch C; Han N; Human J; Liu Q; Norman MH; Riahi B; Yuan C; Suzuki H; Mareska DA; Zhan J; Clarke DE; Toro A; Groneberg RD; Burgess LE; Lester-Zeiner D; Biddlecome G; Manning BH; Arik L; Dong H; Huang M; Kamassah A; Loeloff R; Sun H; Hsieh FY; Kumar G; Ng GY; Hungate RW; Askew BC; Johnson E
J Med Chem; 2007 May; 50(9):2200-12. PubMed ID: 17408249
[TBL] [Abstract][Full Text] [Related]
8. 2,3-Diaminopyridine as a platform for designing structurally unique nonpeptide bradykinin B1 receptor antagonists.
Feng DM; Wai JM; Kuduk SD; Ng C; Murphy KL; Ransom RW; Reiss D; Chang RS; Harrell CM; MacNeil T; Tang C; Prueksaritanont T; Freidinger RM; Pettibone DJ; Bock MG
Bioorg Med Chem Lett; 2005 May; 15(9):2385-8. PubMed ID: 15837330
[TBL] [Abstract][Full Text] [Related]
9. Discovery of a potent, non-peptide bradykinin B1 receptor antagonist.
Su DS; Markowitz MK; DiPardo RM; Murphy KL; Harrell CM; O'Malley SS; Ransom RW; Chang RS; Ha S; Hess FJ; Pettibone DJ; Mason GS; Boyce S; Freidinger RM; Bock MG
J Am Chem Soc; 2003 Jun; 125(25):7516-7. PubMed ID: 12812482
[TBL] [Abstract][Full Text] [Related]
10. Aryl sulfones as novel bradykinin B1 receptor antagonists for treatment of chronic pain.
Biswas K; Aya T; Qian W; Peterkin TA; Chen JJ; Human J; Hungate RW; Kumar G; Arik L; Lester-Zeiner D; Biddlecome G; Manning BH; Sun H; Dong H; Huang M; Loeloff R; Johnson EJ; Askew BC
Bioorg Med Chem Lett; 2008 Sep; 18(17):4764-9. PubMed ID: 18706809
[TBL] [Abstract][Full Text] [Related]
11. Identification of a nonpeptidic and conformationally restricted bradykinin B1 receptor antagonist with anti-inflammatory activity.
D'Amico DC; Aya T; Human J; Fotsch C; Chen JJ; Biswas K; Riahi B; Norman MH; Willoughby CA; Hungate R; Reider PJ; Biddlecome G; Lester-Zeiner D; Staden CV; Johnson E; Kamassah A; Arik L; Wang J; Viswanadhan VN; Groneberg RD; Zhan J; Suzuki H; Toro A; Mareska DA; Clarke DE; Harvey DM; Burgess LE; Laird ER; Askew B; Ng G
J Med Chem; 2007 Feb; 50(4):607-10. PubMed ID: 17243660
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological, pharmacokinetic, and primate analgesic efficacy profile of the novel bradykinin B1 Receptor antagonist ELN441958.
Hawkinson JE; Szoke BG; Garofalo AW; Hom DS; Zhang H; Dreyer M; Fukuda JY; Chen L; Samant B; Simmonds S; Zeitz KP; Wadsworth A; Liao A; Chavez RA; Zmolek W; Ruslim L; Bova MP; Holcomb R; Butelman ER; Ko MC; Malmberg AB
J Pharmacol Exp Ther; 2007 Aug; 322(2):619-30. PubMed ID: 17470643
[TBL] [Abstract][Full Text] [Related]
13. Alpha-hydroxy amides as a novel class of bradykinin B1 selective antagonists.
Wood MR; Schirripa KM; Kim JJ; Kuduk SD; Chang RK; Di Marco CN; DiPardo RM; Wan BL; Murphy KL; Ransom RW; Chang RS; Holahan MA; Cook JJ; Lemaire W; Mosser SD; Bednar RA; Tang C; Prueksaritanont T; Wallace AA; Mei Q; Yu J; Bohn DL; Clayton FC; Adarayn ED; Sitko GR; Leonard YM; Freidinger RM; Pettibone DJ; Bock MG
Bioorg Med Chem Lett; 2008 Jan; 18(2):716-20. PubMed ID: 18061443
[TBL] [Abstract][Full Text] [Related]
14. Small molecule bradykinin B1 receptor antagonists as potential therapeutic agents for pain.
Chen JJ; Biswas K
Prog Med Chem; 2008; 46():173-204. PubMed ID: 18381126
[No Abstract] [Full Text] [Related]
15. 2-Aminobenzophenones as a novel class of bradykinin B1 receptor antagonists.
Su DS; Lim JL; Tinney E; Wan BL; Murphy KL; Reiss DR; Harrell CM; O'Malley SS; Ransom RW; Chang RS; Pettibone DJ; Yu J; Tang C; Prueksaritanont T; Freidinger RM; Bock MG; Anthony NJ
J Med Chem; 2008 Jul; 51(13):3946-52. PubMed ID: 18553956
[TBL] [Abstract][Full Text] [Related]
16. Non-peptide antagonists for kinin B1 receptors: new insights into their therapeutic potential for the management of inflammation and pain.
Campos MM; Leal PC; Yunes RA; Calixto JB
Trends Pharmacol Sci; 2006 Dec; 27(12):646-51. PubMed ID: 17056130
[TBL] [Abstract][Full Text] [Related]
17. Antinociceptive pharmacology of N-[[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]methyl]-2-[2-[[(4-methoxy-2,6-dimethylphenyl) sulfonyl]methylamino]ethoxy]-N-methylacetamide, fumarate (LF22-0542), a novel nonpeptidic bradykinin B1 receptor antagonist.
Porreca F; Vanderah TW; Guo W; Barth M; Dodey P; Peyrou V; Luccarini JM; Junien JL; Pruneau D
J Pharmacol Exp Ther; 2006 Jul; 318(1):195-205. PubMed ID: 16565167
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, analgesic and anti-inflammatory evaluation of some new 3H-quinazolin-4-one derivatives.
Alafeefy AM; Kadi AA; El-Azab AS; Abdel-Hamide SG; Daba MH
Arch Pharm (Weinheim); 2008 Jun; 341(6):377-85. PubMed ID: 18535995
[TBL] [Abstract][Full Text] [Related]
19. Identification and biological evaluation of 4-(3-trifluoromethylpyridin-2-yl)piperazine-1-carboxylic acid (5-trifluoromethylpyridin-2-yl)amide, a high affinity TRPV1 (VR1) vanilloid receptor antagonist.
Swanson DM; Dubin AE; Shah C; Nasser N; Chang L; Dax SL; Jetter M; Breitenbucher JG; Liu C; Mazur C; Lord B; Gonzales L; Hoey K; Rizzolio M; Bogenstaetter M; Codd EE; Lee DH; Zhang SP; Chaplan SR; Carruthers NI
J Med Chem; 2005 Mar; 48(6):1857-72. PubMed ID: 15771431
[TBL] [Abstract][Full Text] [Related]
20. Bradykinin B1 receptor antagonists as potential therapeutic agents for pain.
Huang H; Player MR
J Med Chem; 2010 Aug; 53(15):5383-99. PubMed ID: 20369879
[No Abstract] [Full Text] [Related]
[Next] [New Search]
